Difficulty: Medium
Average Score: 84%
Practice
The U.S. Food and Drug Administration (FDA) recommends genetic testing of patients receiving certain medications. Genetic testing helps prescribers:
Correct answer
B
Rationale
In the context of pharmacology, genetic testing plays a crucial role in determining how patients metabolize certain medications. The correct answer, B) determine whether a patient is a rapid or slow metabolizer of the drug, is the most appropriate choice because it directly addresses the primary purpose of genetic testing in pharmacogenomics.
Genetic variations can influence how individuals process medications, leading to differences in drug efficacy and potential side effects. Identifying whether a patient is a rapid metabolizer (where drugs are broken down quickly, potentially leading to reduced efficacy) or a slow metabolizer (where drugs are broken down slowly, potentially causing toxicity) is essential for personalized medicine.
Option A) better establishing a drug's therapeutic index is incorrect because genetic testing does not directly determine the therapeutic index of a drug; it focuses on individual patient variability.
Option C) identifying racial characteristics that affect psychosocial variation in drug response is incorrect as genetic testing is more focused on individual genetic variations rather than broad racial characteristics.
Option D) producing a drug tailored to an individual patient's genetic makeup is incorrect as genetic testing is used to optimize the selection and dosing of existing medications based on the patient's genetic profile, rather than creating new drugs.
In an educational context, understanding the impact of genetic variability on drug metabolism is crucial for nursing practice. By recognizing how genetic testing can inform medication management, nurses can provide safer and more effective care tailored to individual patients, ultimately improving outcomes and minimizing adverse reactions.
Genetic variations can influence how individuals process medications, leading to differences in drug efficacy and potential side effects. Identifying whether a patient is a rapid metabolizer (where drugs are broken down quickly, potentially leading to reduced efficacy) or a slow metabolizer (where drugs are broken down slowly, potentially causing toxicity) is essential for personalized medicine.
Option A) better establishing a drug's therapeutic index is incorrect because genetic testing does not directly determine the therapeutic index of a drug; it focuses on individual patient variability.
Option C) identifying racial characteristics that affect psychosocial variation in drug response is incorrect as genetic testing is more focused on individual genetic variations rather than broad racial characteristics.
Option D) producing a drug tailored to an individual patient's genetic makeup is incorrect as genetic testing is used to optimize the selection and dosing of existing medications based on the patient's genetic profile, rather than creating new drugs.
In an educational context, understanding the impact of genetic variability on drug metabolism is crucial for nursing practice. By recognizing how genetic testing can inform medication management, nurses can provide safer and more effective care tailored to individual patients, ultimately improving outcomes and minimizing adverse reactions.